ACHE and Alzheimer disease: Loss in cholinergic neuro-transformation and neurons can decrease the ACh levels, and the cholinergic hypothesis states that the enhancement in the ACh and inhibition of acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) levels can ameliorate the cognitive and memory functions in AD patients (6).